Type 2 & other diabetes

Effects of combined intraduodenal administration of lauric acid and l-tryptophan on postprandial plasma glucose, glucoregulatory hormones and gastric emptying in type 2 diabetes: a double-blind, randomised, crossover study

DiabetologiaPublished Randomised crossover trial

Authors' conclusion

In type 2 diabetes, intraduodenal C12+Trp lowers postprandial glucose, probably primarily by slowing of gastric emptying and mediated by GLP-1 and CCK. These findings support further exploration of nutrient-based gastrointestinal strategies to optimise glycaemic management in type 2 diabetes.

Study context

Population
Men with T2D (age 69 ± 7 years; HbA1c 51 ± 5 mmol/mol [6.8 ± 0.3%]; BMI 28 ± 1 kg/m²), University of Adelaide Clinical Research Facilitycrossover, 4 occasions
Participants
11 men
Comparison
Intraduodenal C12, Trp, C12+Trp vs saline control before a mixed-nutrient drink
Primary endpoint
Postprandial plasma glucose
Follow-up
180 min post-drink
Methodological detailsdouble-blind (investigators and participants), single-centre
  • Double-blind (investigators and participants)
  • Single-centre

Primary result

As reported in the abstract

Peak plasma glucose

P = 0.01

C12+Trp, but not C12 or Trp, reduced overall plasma glucose
P = 0.02

Further findings

Gastric emptying (13C-acetate breath test)

C12+Trp slowed gastric emptying
P = 0.001

Pre-drink plasma GLP-1, GIP and CCK

C12+Trp increased pre-drink GLP-1, GIP and CCK
all p<0.05
No effect on insulin or C-peptide

Postprandial hormones

No treatment effects were observed postprandially

Original publication

Effects of combined intraduodenal administration of lauric acid and l-tryptophan on postprandial plasma glucose, glucoregulatory hormones and gastric emptying in type 2 diabetes: a double-blind, randomised, crossover study. Diabetologia. Published 19 December 2025. doi:10.1007/s00125-025-06630-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.